VR as a Facilitator for Participation in Society Among Persons With MHD/SUD
Launched by SYKEHUSET INNLANDET HF · Dec 7, 2022
Trial Information
Current as of January 16, 2025
Active, not recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • above 18 years of age
- • receiving services in the municipality due to mental health and or addiction problems.
- Exclusion Criteria:
- • -visual and hearing impairment, neurological disorders, and mental retardation \[score ≤70 on the Test of Intelligence\].
Trial Officials
Lars Lien, MD, Ph.d
Principal Investigator
Sykehuset Innlandet HF
About Sykehuset Innlandet Hf
Sykehuset Innlandet HF is a prominent healthcare provider in Norway, dedicated to delivering high-quality medical services and advancing clinical research. As a key player in the region's healthcare landscape, the organization operates several hospitals and specialized units, focusing on a wide range of medical disciplines. Sykehuset Innlandet HF is committed to fostering innovative clinical trials that enhance patient care and contribute to the development of new therapies. With a strong emphasis on collaboration and ethical standards, the organization seeks to improve health outcomes through rigorous research and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brumunddal, , Norway
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials